CN111568793A - Acne removing gel and preparation method thereof - Google Patents

Acne removing gel and preparation method thereof Download PDF

Info

Publication number
CN111568793A
CN111568793A CN202010312554.0A CN202010312554A CN111568793A CN 111568793 A CN111568793 A CN 111568793A CN 202010312554 A CN202010312554 A CN 202010312554A CN 111568793 A CN111568793 A CN 111568793A
Authority
CN
China
Prior art keywords
poloxamer
propylene glycol
solution
removing gel
acne removing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010312554.0A
Other languages
Chinese (zh)
Other versions
CN111568793B (en
Inventor
张小燕
邱瑞林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiuyi Biotechnology Co ltd
Original Assignee
Shanghai Jiuyi Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiuyi Biotechnology Co ltd filed Critical Shanghai Jiuyi Biotechnology Co ltd
Priority to CN202010312554.0A priority Critical patent/CN111568793B/en
Publication of CN111568793A publication Critical patent/CN111568793A/en
Application granted granted Critical
Publication of CN111568793B publication Critical patent/CN111568793B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention provides an acne-removing gel and a preparation method thereof, belonging to the field of cosmetics. The acne-removing gel is prepared by dissolving salicylic acid in propylene glycol and adding poloxamer 407; the mass ratio of the propylene glycol to the poloxamer 407 is 1: 1-2. The invention also discloses a preparation method of the acne-removing gel. The salicylic acid is dissolved by the propylene glycol, so that the irritation of the product to skin and pox is reduced, and the utilization rate of an effect substance is improved.

Description

Acne removing gel and preparation method thereof
Technical Field
The invention relates to the field of cosmetics, and particularly relates to an acne-removing gel and a preparation method thereof.
Background
Salicylic acid is a fat-soluble organic acid, and can dissolve the constituent substances between horny layers to cause the horny layer to fall off, so that the horny layer accumulated too thickly can be removed to promote metabolism. The salicylic acid acts on hair follicle wall cells, can help to remove blocked hair follicles, correct abnormal cell shedding, and has an auxiliary effect on pox caused by pore obstruction. Salicylic acid is therefore commonly used in anti-acne products. Salicylic acid is only slightly soluble in water and easily soluble in ethanol, diethyl ether, chloroform, etc., so many products are often added with alcohol as a solvent for salicylic acid. However, a large part of the acne skin belongs to sensitive skin, and the addition of acne causes the destruction of the cuticle, so that adverse reactions such as pain, wound healing inhibition and the like are easily caused after the acne skin contacts alcohol. In addition, the alcohol acne removing product causes the dissolved salicylic acid to precipitate and become a solid crystal state again along with the volatilization of alcohol, thereby influencing the skin absorption and reducing the utilization rate of the efficacy materials. Ethanol toxicology data-rabbit eye: 500mg, heavy stimulation; rabbit percutaneous open stimulation test: 15mg/24 h, moderate stimulation.
Disclosure of Invention
The first purpose of the invention is to provide an acne removing gel.
The second purpose of the invention is to provide a preparation method of the acne removing gel.
In order to achieve the purpose, the acne removing gel provided by the invention is prepared by dissolving salicylic acid in propylene glycol and then adding poloxamer 407; wherein the mass ratio of the propylene glycol to the poloxamer 407 is 1: 1-2.
The invention also provides a preparation method of the acne removing gel, which comprises the following specific steps:
s1, dissolving 10g of poloxamer 407 in 50-100g of deionized water at room temperature, standing and refrigerating;
s2, adding 1g of salicylic acid into 5-10g of propylene glycol, and heating to 45-55 ℃ for dissolution;
and S3, taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform to obtain the poloxamer.
Wherein the mass ratio of the poloxamer 407 to the deionized water in the step S1 is 1: 5-10.
Wherein the refrigeration temperature in step S1 is 5 ℃.
Wherein the refrigerating time in the step S1 is 8-12 h.
Wherein the mass ratio of the salicylic acid to the propylene glycol in the step S2 is 1: 5-10.
Propylene glycol belongs to a low-irritation and low-toxicity solvent, and rats are injected intravenously and intraperitoneally with LD507000-8000mg/kg, oral LD50It was 2800 mg/kg. Poise (a Chinese character)Loxam 407 was used as a stabilizer for salicylic acid, which forms micelles in water, increasing the surface solubility of salicylic acid; poloxamer 407 has good compatibility with skin, can be used as an absorption enhancer, and can increase the absorption and utilization of salicylic acid by skin; poloxamer 407 as a high molecular material for preparing the temperature-sensitive in-situ gel has the advantages of good spreadability, large mucous membrane coverage, long detention time, simple preparation, convenient use and the like.
The invention has the beneficial effects that:
according to the invention, the propylene glycol is used as a solvent, so that the stimulation of the use of alcohol to the skin in the traditional process is reduced, and the propylene glycol and the poloxamer 407 in a specific proportion can effectively improve the acne removing effect of the acne removing gel. The invention has simple process, good product effect and better use value.
Detailed Description
In order to more clearly and completely describe the technical scheme of the invention, the invention is further described in detail by the specific embodiments, and it should be understood that the specific embodiments described herein are only used for explaining the invention, and are not used for limiting the invention, and various changes can be made within the scope defined by the claims of the invention.
Example 1
Adding 10g of poloxamer 407 into 100g of deionized water at room temperature, standing in a refrigerating chamber at 5 ℃ for 8 h; 1g of salicylic acid is added to 10g of propylene glycol; heating to 45 ℃ to dissolve; and taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform.
Example 2
Adding 10g of poloxamer 407 into 50g of deionized water at room temperature, standing in a refrigerating chamber at 5 ℃ for 10 hours; 1g of salicylic acid was added to 7.5g of propylene glycol; heating to 50 ℃ to dissolve; and taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform.
Example 3
Adding 10g of poloxamer 407 into 50-100g of deionized water at room temperature, standing in a refrigerating chamber at 5 ℃ for 12 hours; 1g of salicylic acid is added to 5g of propylene glycol; heating to 55 ℃ for dissolution; and taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform.
Comparative example 1
Adding 10g of poloxamer 407 into 100g of deionized water at room temperature, standing in a refrigerating chamber at 5 ℃ for 8 h; adding 1g of salicylic acid to 15g of propylene glycol; heating to 45 ℃ to dissolve; and taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform.
Comparative example 2
Adding 5g of poloxamer 407 into 100g of deionized water at room temperature, standing in a refrigerating chamber at 5 ℃ for 8 h; 1g of salicylic acid is added to 10g of propylene glycol; heating to 45 ℃ to dissolve; and taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform.
Performance evaluation:
100 acne patients were selected for the trial, with male and female halves, ages 20-30 years, and a mean age of 24 years. The average was divided into 5 groups (male and female halves), and the acne removing gels prepared in examples and comparative examples were used for experience. The composition is administered once a day for 2 weeks, and then the therapeutic effect is evaluated. The evaluation was divided into: 1. and (3) curing: the skin loss is reduced by more than 90 percent, and no new rash symptoms appear; 2. the effect is shown: the skin loss is reduced by more than 60 percent, and the symptoms are obviously relieved; 3. the method has the following advantages: the skin loss is reduced by more than 30 percent, and the symptoms are improved; 4. and (4) invalidation: the skin loss resolved below 30% with no significant change in symptoms. The evaluation results are shown in table 1.
TABLE 1
Examples Cure of disease Show effect Is effective Invalidation Total effective rate
Example 1 1 12 6 1 95%
Example 2 3 13 4 0 100%
Example 3 2 10 6 2 90%
Comparative example 1 0 3 12 5 75%
Comparative example 2 0 4 10 6 70%
The performance evaluation effect of the table 2 shows that the acne removing gel provided by the invention has a good acne removing effect, and the effect of the comparative example shows that when the ratio of the propylene glycol to the poloxamer 407 exceeds 1:1-2, the acne removing effect is poor, and no curing effect is achieved.
Finally, it should be emphasized that the above-described preferred embodiments of the present invention are merely examples of implementations, rather than limitations, and that many variations and modifications of the invention are possible to those skilled in the art, without departing from the spirit and scope of the invention.

Claims (6)

1. An acne removing gel is characterized in that the acne removing gel is prepared by dissolving salicylic acid in propylene glycol and then adding poloxamer 407; the mass ratio of the propylene glycol to the poloxamer 407 is 1: 1-2.
2. The preparation method of the acne removing gel is characterized by comprising the following specific steps:
s1, dissolving poloxamer 407 in deionized water at room temperature, standing and refrigerating;
s2, adding salicylic acid into propylene glycol, and heating to 45-55 ℃ to dissolve;
and S3, taking out the completely dissolved poloxamer 407 aqueous solution, slowly pouring the dissolved propylene glycol salicylate solution into the solution, and stirring the solution at room temperature until the solution is uniform to obtain the poloxamer.
3. The preparation method of the acne removing gel according to claim 2, wherein the mass ratio of the poloxamer 407 to the deionized water in step S1 is 1: 5-10.
4. The method for preparing the acne removing gel according to claim 2, wherein the refrigeration temperature in step S1 is 5 ℃.
5. The preparation method of the acne removing gel according to claim 2, wherein the refrigerating time in step S1 is 8-12 h.
6. The preparation method of the acne removing gel according to claim 2, wherein the mass ratio of the salicylic acid to the propylene glycol in step S2 is 1: 5-10.
CN202010312554.0A 2020-04-20 2020-04-20 Acne removing gel and preparation method thereof Active CN111568793B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010312554.0A CN111568793B (en) 2020-04-20 2020-04-20 Acne removing gel and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010312554.0A CN111568793B (en) 2020-04-20 2020-04-20 Acne removing gel and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111568793A true CN111568793A (en) 2020-08-25
CN111568793B CN111568793B (en) 2023-04-07

Family

ID=72089993

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010312554.0A Active CN111568793B (en) 2020-04-20 2020-04-20 Acne removing gel and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111568793B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585575A1 (en) * 1985-08-01 1987-02-06 Pf Medicament Pharmaceutical compositions having keratolytic activity in the form of an aqueous alcoholic gel containing salicylic acid
US20160279162A1 (en) * 2013-11-18 2016-09-29 Polyremedy, Inc. Micelle-based delivery of dermal therapeutic materials
CN107108905A (en) * 2014-11-20 2017-08-29 博任达生化科技有限公司 Water-soluble supramolecular complex
CN109771333A (en) * 2019-01-18 2019-05-21 德之馨(上海)有限公司 Salicylic acid solubilising slow releasing composition and its preparation method and application
CN110840834A (en) * 2019-12-09 2020-02-28 山东光普医疗科技有限公司 Preparation process of 30% concentration liquid slow-release salicylic acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585575A1 (en) * 1985-08-01 1987-02-06 Pf Medicament Pharmaceutical compositions having keratolytic activity in the form of an aqueous alcoholic gel containing salicylic acid
US20160279162A1 (en) * 2013-11-18 2016-09-29 Polyremedy, Inc. Micelle-based delivery of dermal therapeutic materials
CN107108905A (en) * 2014-11-20 2017-08-29 博任达生化科技有限公司 Water-soluble supramolecular complex
CN109771333A (en) * 2019-01-18 2019-05-21 德之馨(上海)有限公司 Salicylic acid solubilising slow releasing composition and its preparation method and application
CN110840834A (en) * 2019-12-09 2020-02-28 山东光普医疗科技有限公司 Preparation process of 30% concentration liquid slow-release salicylic acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘文: "《药用高分子材料学》", 30 June 2017, 中国中医药出版社 *
唐星: "《药剂学》", 31 December 2019, 中国医药科技出版社 *
黄珍珍 等: "凝胶剂的研究及应用概况", 《中南药学》 *

Also Published As

Publication number Publication date
CN111568793B (en) 2023-04-07

Similar Documents

Publication Publication Date Title
EP1473300B1 (en) Pharmaceutical composition for the treatment of psoriasis and other skin diseases
CN113975280B (en) Pharmaceutical composition containing tofacitinib pharmaceutically acceptable salt, preparation and application
WO2022105225A1 (en) Azelaic acid gel, preparation method therefor and application thereof
WO2022178983A1 (en) External preparation of natural drug, preparation method, and application thereof
CN111568793B (en) Acne removing gel and preparation method thereof
EP2854784B1 (en) Method for treating skin inflammatory diseases
CN113332161A (en) Ammonium glycyrrhetate hydrogel as well as preparation method and application thereof
CN110840834B (en) Preparation process of 30% concentration liquid slow-release salicylic acid
US11235016B2 (en) Use of a vegetal extract as an active agent in tissue re-epithelizing and cicatrizing processes
CN102247374B (en) Application of tetrahydropyrimidin and derivative thereof in preparation of medicament for treating skin wound
TWI686207B (en) Cleansing cream and preparation method thereof
CN103520232B (en) A kind of preparation method of gel
CN110693895A (en) Pharmaceutical composition for treating hemorrhoids and preparation thereof
JP2860550B2 (en) Acute skin inflammation treatment
CN103211755A (en) Production method of sterile stable azithromycin eye drops
KR101982837B1 (en) Melting method for sucralfate, liquid cosmetics involving sucralfate and method for producing thereof
CN108094408B (en) Pathological tissue preservation stationary liquid
CN106943348B (en) Ethacridine lactate oil film agent and preparation method thereof
EP4081190B1 (en) Composition for suppositories for the treatment of the prostatic diseases
CN110664668A (en) Acne-removing skin-care gel containing water-soluble cannabidiol and preparation method thereof
CN105853404A (en) Compound used for treating acne and application thereof
JP2518704B2 (en) Zinc cysteate, method for producing the same, and use in medicine and cosmetics
JP4717970B2 (en) Antiplasmin
US20230310317A1 (en) Sol-gel composition
CN114504581A (en) Compound triamcinolone acetonide salicylic acid liniment

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant